1. Increased Glycolytic Activity Is Part of Impeded M1(LPS) Macrophage Polarization in the Presence of Urolithin A#.
- Author
-
Bahiraii, Sheyda, Braunböck-Müller, Barbara, and Heiss, Elke H.
- Subjects
- *
ANTI-inflammatory agents , *GLYCOLYSIS , *MACROPHAGES , *MITOCHONDRIA , *RESEARCH funding , *MICE , *LIPOPOLYSACCHARIDES , *ANIMAL experimentation , *OXIDOREDUCTASES , *BENZOPYRANS , *INTERLEUKIN-1 , *INTERLEUKINS , *PHARMACODYNAMICS - Abstract
Urolithin A is a gut metabolite of ellagitannins and reported to confer health benefits, e.g., by increased clearance of damaged mitochondria by macroautophagy or curbed inflammation. One targeted cell type are macrophages, which are plastic and able to adopt pro- or anti-inflammatory polarization states, usually assigned as M1 and M2 macrophages, respectively. This flexibility is tightly coupled to characteristic shifts in metabolism, such as increased glycolysis in M1 macrophages, and protein expression upon appropriate stimulation. This study aimed at investigating whether the anti-inflammatory properties of u rolithin A may be driven by metabolic alterations in cultivated murine M1(lipopolysaccharide) macrophages. Expression and extracellular flux analyses showed that urolithin A led to reduced il1β, il6 , and nos2 expression and boosted glycolytic activity in M1(lipopolysaccharide) macrophages. The pro-glycolytic feature of urolithin A occurred in order to causally contribute to its anti-inflammatory potential, based on experiments in cells with impeded glycolysis. Mdivi, an inhibitor of mitochondrial fission, blunted increased glycolytic activity and reduced M1 marker expression in M1(lipopolysaccharide/ urolithin A), indicating that segregation of mitochondria was a prerequisite for both actions of urolithin A. Overall, we uncovered a so far unappreciated metabolic facet within the anti-inflammatory activity of urolithin A and call for caution about the simplified notion of increased aerobic glycolysis as an inevitably proinflammatory feature in macrophages upon exposure to natural products. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF